Clinical Trial Update: A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HRS-1167 tablets in combination with abiraterone acetate and prednisone for metastatic prostate cancer is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• HRS-1167
• PREDNISONE (Prednisone)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING